Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02339285 · ClinicalTrials.gov registry record · NA
Transcranial Alternating Current Stimulation for Major Depressive Disorder
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02339285 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 32 participants.
The verdict
NCT02339285, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Investigating the effects of non-invasive transcranial alternating current stimulation (tACS) on patients with Major Depressive Disorder (MDD).
Interventions
- DEVICE tACS (alpha)
- DEVICE tACS (gamma)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-05-07 |
| Est. Completion | 2017-06-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02339285
The ClinicalTrials.gov registry entry for NCT02339285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which tACS (alpha) is the first listed.
NCT02339285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02339285 about?
NCT02339285 is a clinical study titled "Transcranial Alternating Current Stimulation for Major Depressive Disorder". Investigating the effects of non-invasive transcranial alternating current stimulation (tACS) on patients with Major Depressive Disorder (MDD).
What is the current status of trial NCT02339285?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2015-05-07. Estimated completion is 2017-06-19.
What interventions are being tested in trial NCT02339285?
The interventions under investigation include: tACS (alpha) (DEVICE), tACS (gamma) (DEVICE).
Who is sponsoring clinical trial NCT02339285?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.